Specifically, for certain cancer entities, it has been reported that EZH2 stimulates cell proliferation, blocks apoptosis, promotes cell invasion and metastasis, activates tumor angiogenesis, and induces tumors in mouse models [2]–[11]. The gene discussed is EZH2; the disease is cancer.